SCHEMBL5181365

SCHEMBL5181365

Nc1nc2c(c(=O)[nH]1)NCN2CC(CO)C(O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 9/20 0.61
NOS1 P29475 4/20 0.34
USP2 O75604 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PAH P00439 1/20 0.34
ALDH1A1 P00352 2/20 0.34
BLM P54132 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
PMP22 Q01453 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
NFKB1 P19838 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL711245 0.88 HPRT1 (0.55) HPRT1NOS1USP2CASP7HSD17B10
SCHEMBL7142937 0.87 HPRT1 (0.64) HPRT1NOS1USP2CASP7HSD17B10
SCHEMBL10919076 0.86 HPRT1 (0.62) HPRT1NOS1USP2CASP7HSD17B10
SCHEMBL7745028 0.85 HPRT1 (0.64) HPRT1NOS1USP2CASP7HSD17B10
SCHEMBL10506613 0.83 HPRT1 (0.54) HPRT1NOS1USP2CASP7HSD17B10
SCHEMBL10919055 0.82 HPRT1 (0.58) HPRT1NOS1USP2CASP7HSD17B10
SCHEMBL10918859 0.82 HPRT1 (0.61) HPRT1NOS1USP2CASP7HSD17B10
SCHEMBL9116476 0.82 HPRT1 (0.54) HPRT1NOS1USP2CASP7HSD17B10
SCHEMBL10507349 0.82 HPRT1 (0.53) HPRT1NOS1USP2CASP7HSD17B10
SCHEMBL417578 0.81 HPRT1 (0.60) HPRT1NOS1USP2CASP7HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249548-A1 Nucleoside Analog or Salts of the Same GIFU UNIVERSITY (JP) 2007-10-25 US disclosed
EP-1798225-A1 NUCLEOSIDE ANALOGUES OR SALTS THEREOF Gifu University (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249548-A1 Nucleoside Analog or Salts of the Same NSUN2, RNMT, RNGTT HPRT1 29/4885NOS1 1335/4885USP2 4796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.